Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Bipolar Disorder
- Mood Disorders
- Substance Use Disorders
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 15 years and 24 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02845453
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Investigators
- Study Chair: Amy Yule, M.D. Boston Medical Center